Sept 2, 2015
Vital Therapies, Inc. (NASDAQ:VTL) Given $5-$6 PT Range
According to the analysts polled by Zack’s Research, Vital Therapies, Inc. (NASDAQ:VTL) has been given a one year consensus price target range of $5 to $6. The average, or consensus number of the polled firms, yields a mean of $5.333.
The same analysts are projecting that Vital Therapies, Inc. (NASDAQ:VTL) will report EPS of $-0.59 when the firm next issues their quarterly earnings release on or around 2015-11-12. In the most recent quarter the company reported earnings of $-0.63 that ended on 2015-06-30.